Who we are

Board of Directors

Name……………………..Designation………………………..Short Description
Stéphane ThiroloixStéphane ThiroloixFounder, President & CEOHEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Olivier BohuonOlivier BohuonCo-FounderChairman of the Board LEO Pharma. External Director Takeda plc. External Director Smiths Group plc. Supervisory Board Member Virbac.
Thibaut RoulonThibaut RoulonMember, BODSenior Investment Director – Life Sciences, Bpifrance. Graduate Ecole Centrale Paris, PhD in Molecular Biophysics P&M Curie University.
Claire PoulardClaire PoulardMember, BODPrincipal, Omnes Capital. Master in Pharm Mgt & Biotech ESCP Europe, Master in Bioengineering & Neuroscience Innovation ESPCI.
Hugues Le BretHugues Le BretMember, BODFounder & Supervisory Board President Compte-Nickel. Adviser to CEO BNP Paribas. Prev President & CEO Boursorama.
Scott ByrdIndependent Member, BODCEO Pioneer Tx, CoB of Acacia Pharma Group.
BS in mechanical eng. & MBA Harvard University.
Ed HarriganIndependent Member, BODBoard Mb at Acadia, Incyte and Phase Bio.
Sc Advisor to Alzheon and Karuna Tx.
BA St Anselm, MD Massachusetts University, Neurology Boston University.

Executive Team

Name……………………..Designation……………………..Short Description
Stéphane ThiroloixStéphane ThiroloixFounder, President & CEOHEC. Board Member at Jellagen. Prev CEO Mayoly-Spindler, EVP Europe Smith&Nephew, EVP Corporate Development IPSEN.
Philippe PicautChief Scientific OfficerPharm D, MSc Tox, MSc Anatomopathology, American Board of Toxicology.
Sr VP Neurosciences R&D, Ipsen
Jens EllrichChief Medical OfficerMD, PhD, Prof of neuroscience at RWTH Aachen & Aalborg University. Sapiens, WISE, EBS Technologies, BIAL, Precisis.
Paola Principe-NicolasPaola Principe-NicolasR&D Project MgtPhD in genetics and cell biochemistry. Development expertise in oncology, neurology and endocrinology. Ipsen, PNP Pharmac
France CatusFrance CatusClinical Operations ManagerMD. Statistics DIU (Cesam). Ipsen Medical Dvt Dir, Clin Dvt Dir.
Steve ScottSteve ScottUS Regulatory OfficerFounder, PDR for Pharma. Ipsen VP North American Reg Aff,Biomeasure, Pharma Dvt Resources, Sepracor, Parexel, Interferon Sciences
Etienne BienfaitEtienne BienfaitFinance & Admin ManagerEngineer, Research Master in Business Mgt. Covage, Bryan Garnier

Scientific Advisory Board

Name……………………..Designation………….Short Description
Céline GrecoCéline GrecoChair, SABMD PhD. Hosp. Practitioner, Dpt of neonatal, pediatric & adult pain and palliative medicine, Hop Necker Enfants Malades, Paris, France.
Ronald LevyRonald LevyMember, SABProf of Medicine. Stanford U Dpt of Oncology, Faisal Intl Prize, Damashek Prize, American Cancer Society’s Medal of Honor.
Jean-François BergmannJean-François BergmannMember, SABProf Therapeutics, Paris VII U. Previously : Head Intl Med & Inf Dis H. Lariboisière, expert EMA, VP ANSM Drug Auth Ctee & Transparency Ctee
Philippe ArnaudPhilippe ArnaudMember, SABPharm D, Hosp. Pharmacist, APHP Paris. Prof, Faculty of Pharmacy, Paris. Erasmus Prof, Portugal. Prev Member of French Medicines Agency ANSM
Alain EschalierAlain EschalierMember, SABPharmacist, Medical Doctor and Pharmacologist. Professor of Medical Pharmacology, former President of the Université d’Auvergne, France.
Axel Le CesneAxel Le CesneMember, SABAssoc Prof of Medicine. Head of Medical Onclogy Hospital Unit, Gustave Roussy, France.
Roy FreemanRoy FreemanMember, SABMD. Prof Neurology, Harvard Med School. Dir Cntr for Autonomic and Periph Nerve Disorders at Beth Israel Deaconess Medical Ctr, Boston, Ma.